Vascular disease continues to be a leading cause of morbidity and mortality worldwide. The SVDx test leverages state-of-the-art technology to provide comprehensive insights into a patient’s ...

MorningStar Laboratories, LLC., (“MSL” or “the Company”), is a leading developer of precision diagnostic tests that address unmet clinical needs, is proud to announce its expansion in the Midwest with ...

A new study from UCLA Health has uncovered how inflammation in brain blood vessels exacerbates damage in vascular dementia ...

A new study from UCLA Health has uncovered how inflammation in brain blood vessels exacerbates damage in vascular dementia and demonstrated that targeting this process with a repurposed drug can ...

SmartVascular™ Test: Revolutionizing Vascular Risk Assessment Nationwide Provided by GlobeNewswire Jun 11, 2025, 6:21:05 PM. IRVINE, Calif., June 11, 2025 (GLOBE NEWSWIRE) ...

Vascular disease continues to be a leading cause of morbidity and mortality worldwide. The SVDx test leverages state-of-the-art technology to provide comprehensive insights into a patient’s ...

SmartVascular Dx™ Test: Enhancing Vascular Care in the Midwest Provided by GlobeNewswire Jun 25, 2025, 10:00:00 AM. IRVINE, Calif., June 25, 2025 (GLOBE NEWSWIRE) ...

MorningStar Laboratories, LLC ('MSL” or 'the Company”), a leading developer of precision diagnostic tests that address unmet clinical needs, proudly announces its SmartVascular Dx™ (SVDx) test ...

IRVINE, Calif., June 11, 2025 (GLOBE NEWSWIRE) -- MorningStar Laboratories, LLC (“MSL” or “the Company”), a leading developer of precision diagnostic tests that address unmet clinical needs, proudly ...